Precise activation and tracking of cancer treatment with a new compound is possible

This class of inhibitors has shown therapeutic promise in several cancer types, including chronic lymphocytic leukemia and Burkitt lymphoma

Related Keywords

Texas ,United States ,America ,Texans ,Dylan Horton ,Kimberlee Speakman ,Wistar Institute ,University Of South Florida ,Microenvironment Metastasis Program ,South Florida ,Metastasis Program ,Enhanced Anticancer Compound May Allow ,Precise Activation ,Good Morning America ,